Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease (original) (raw)

Inflammatory Responses to Amyloidosis in a Transgenic Mouse Model of Alzheimer’s Disease

Cynthia Lemere

The American Journal of Pathology, 2001

View PDFchevron_right

Amyloid Plaque and Neurofibrillary Tangle Pathology in a Regulatable Mouse Model of Alzheimer's Disease

Jennifer Paulson

The American Journal of Pathology, 2008

View PDFchevron_right

Association of Microglia with Amyloid Plaques in Brains of APP23 Transgenic Mice

Bernd Sommer

The American Journal of Pathology, 1999

View PDFchevron_right

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

kim weiss

Nature Medicine, 2000

View PDFchevron_right

Animal models of amyloid-β-related pathologies in Alzheimer’s disease

Paul O'Callaghan

FEBS Journal, 2010

View PDFchevron_right

The Role of Complement and Activated Microglia in the Pathogenesis of Alzheimer's Disease

piet eikelenboom

Neurobiology of Aging, 1996

View PDFchevron_right

Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease

André Manook

PLoS ONE, 2009

View PDFchevron_right

Microglial response to amyloid plaques in APPsw transgenic mice

Fusheng Yang

The American journal of pathology, 1998

View PDFchevron_right

Epitope and isotype specificities of antibodies to -amyloid peptide for protection against Alzheimer's disease-like neuropathology

minh nguyen

Proceedings of The National Academy of Sciences, 2003

View PDFchevron_right

Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease

Claudia Schäfer, P Mathews, Heidrun Wölfing

Proceedings of the National Academy of Sciences, 2010

View PDFchevron_right

Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease

Sandra Villegas

mAbs, 2013

View PDFchevron_right

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Bernd Sommer

Proceedings of the National Academy of Sciences, 1997

View PDFchevron_right

Immunotherapy for Alzheimer's disease: attacking amyloid-� from the inside

Beka Solomon

Trends Immunol, 2007

View PDFchevron_right

Novel Aβ peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease

Maria Isabel Burgos Fonseca

2005

View PDFchevron_right

Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines*

Leszek Kotula

Neuropathology and Applied Neurobiology, 1996

View PDFchevron_right

Aβ-Induced Inflammatory Processes in Microglia Cells of APP23 Transgenic Mice

Bernd Sommer

The American Journal of Pathology, 2001

View PDFchevron_right

Alzheimer Disease Pathology As a Host Response

Mark Smith

Journal of Neuropathology & Experimental Neurology, 2008

View PDFchevron_right

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition

A. Rojiani

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004

View PDFchevron_right

A transgenic rat model of Alzheimer's disease with extracellular Aβ deposition

Dorothy Flood

Neurobiology of Aging, 2009

View PDFchevron_right

Beta-amyloid and oxidative stress in the pathogenesis of Alzheimer's Disease

GeraldnEls Veurink

1999

View PDFchevron_right

Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease

Maria Isabel Burgos Fonseca

Journal of Neuroinflammation, 2011

View PDFchevron_right

Insights into Alzheimer disease pathogenesis from studies in transgenic animal models

Wagner Gattaz

Clinics, 2011

View PDFchevron_right

Immunotherapy for Alzheimer's disease: attacking amyloid-â from the inside

Beka Solomon

Trends in Immunology, 2007

View PDFchevron_right

Staining of Amyloid Beta (Abeta) Using (Immuno) Histochemical Techniques and Abeta42 Specific Peptides

Inga Kadish

Neuroimaging for Clinicians - Combining Research and Practice, 2011

View PDFchevron_right

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

John Lambris

Proceedings of the National Academy of Sciences, 2002

View PDFchevron_right

An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease

Dag Sehlin

Neurobiology of Disease, 2009

View PDFchevron_right

Emerging concepts of how β-amyloid proteins and pro-inflammatory cytokines might collaborate to produce an ‘Alzheimer brain’ (Review)

Ilaria Dal Prà

Molecular Medicine Reports, 2008

View PDFchevron_right